Sodium hydride → 9-[(2,4-Diaminopyrimidin-5-yl)methyl]-9,10-dihydrodibenz[b,f]azepine
Reaktionsgleichung
NC1N=C(N)C2C(=NC=C(CN(C3C=CC=CC=3)C3C=CC=CC=3)N=2)N=1.[CH:27]1[C:37]2[C:31](=[N:32][C:33]3[CH:41]=[CH:40][CH2:39][CH2:38][C:34]=3[CH2:35][CH:36]=2)[CH:30]=[CH:29][CH:28]=1.[H-].[Na+].Br.[NH2:45][C:46]1[N:51]=[C:50]([NH2:52])[C:49]([CH2:53]Br)=[CH:48][N:47]=1>>[NH2:45][C:46]1[N:51]=[C:50]([NH2:52])[C:49]([CH2:53][CH:38]2[C:34]3[CH2:35][CH:36]=[C:37]4[CH:27]=[CH:28][CH:29]=[CH:30][C:31]4=[N:32][C:33]=3[CH:41]=[CH:40][CH2:39]2)=[CH:48][N:47]=1Komponenten
5
Versuchsvorschrift
9-[(2,4-Diaminopyrimidin-5-yl)methyl]-9,10-dihydrodibenz[b,f]azepine (Formula I: Ar=2,4-diaminopyrimidin-5-yl; W=CH2; X=N; Z=CH═CH; m=n=0) is prepared similarly to N-[(2,4-diaminopteridin-6-yl)methyl]-N,N-diphenylamine as disclosed above by using 9,10-dihydrodibenz[b,f]azepine (158 mg, 0.8 mmol), NaH (50 mg, 2.1 mmol), and 2,4-diamino-5-bromomethylpyrimidine hydrobromide (86 mg, 0.3 mmol). The product can be purified by chromatography.
Aufarbeitung
- customThe product can be purified by chromatography
Quellen und Nachweise
- ORD-Eintrag
- ord-9e038303e79e4d039732e6b77794cbef
- Quelldatensatz
- uspto-grants-2006_06
- Patentnummer
- US07056911B1
Notizen zur Reaktion
Wird geladen…